Literature DB >> 10214102

Prevalence and correlates of hepatitis C virus infection among inmates entering the California correctional system.

J D Ruiz1, F Molitor, R K Sun, J Mikanda, M Facer, J M Colford, G W Rutherford, M S Ascher.   

Abstract

To estimate the prevalence and predictors of hepatitis C virus (HCV) infection among inmates, a cross-sectional survey was conducted in 1994 among inmates entering six reception centers of the California Department of Corrections. Discarded serum samples were tested for antibodies to human immunodeficiency virus (HIV), HCV, hepatitis B core, and hepatitis B surface antigen (HBsAg). Of 4,513 inmates in this study, 87.0% were men and 13.0% were women. Among male inmates, 39.4% were anti-HCV-positive; by race/ethnicity, prevalences were highest among whites (49.1%). Among female inmates, 53.5% were anti-HCV-positive; the prevalence was highest among Latinas (69.7%). In addition, rates for HIV were 2.5% for men and 3.1% for women; and for HBsAg, 2.2% (men) and 1.2% (women). These data indicate that HCV infection is common among both men and women entering prison. The high seroprevalence of anti-HCV-positive inmates may reflect an increased prevalence of high-risk behaviors and should be of concern to the communities to which these inmates will be released.

Entities:  

Mesh:

Year:  1999        PMID: 10214102      PMCID: PMC1305533     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  21 in total

Review 1.  Virology, molecular biology, and serology of hepatitis C virus.

Authors:  D W Bradley
Journal:  Transfus Med Rev       Date:  1992-04

2.  HIV antibody seroprevalence among prisoners entering the California correctional system.

Authors:  J A Singleton; C I Perkins; A I Trachtenberg; M J Hughes; K W Kizer; M Ascher
Journal:  West J Med       Date:  1990-10

3.  Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection.

Authors:  M J Alter; S C Hadler; F N Judson; A Mares; W J Alexander; P Y Hu; J K Miller; L A Moyer; H A Fields; D W Bradley
Journal:  JAMA       Date:  1990-11-07       Impact factor: 56.272

4.  Prevalence and incidence of hepatitis C virus infection among male prison inmates in Maryland.

Authors:  D Vlahov; K E Nelson; T C Quinn; N Kendig
Journal:  Eur J Epidemiol       Date:  1993-09       Impact factor: 8.082

5.  Prevalence of antibodies to hepatitis C virus and association with intravenous drug abuse and tattooing in a national prison in Norway.

Authors:  D S Holsen; S Harthug; H Myrmel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-09       Impact factor: 3.267

6.  The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team.

Authors:  M J Alter; H S Margolis; K Krawczynski; F N Judson; A Mares; W J Alexander; P Y Hu; J K Miller; M A Gerber; R E Sampliner
Journal:  N Engl J Med       Date:  1992-12-31       Impact factor: 91.245

7.  The prevalence of hepatitis C virus (HCV) in infants and children after liver transplantation.

Authors:  M J Nowicki; N Ahmad; J E Heubi; I K Kuramoto; B M Baroudy; W F Balistreri
Journal:  Dig Dis Sci       Date:  1994-10       Impact factor: 3.199

Review 8.  The epidemiology of viral hepatitis in the United States.

Authors:  M J Alter; E E Mast
Journal:  Gastroenterol Clin North Am       Date:  1994-09       Impact factor: 3.806

9.  Antibody to hepatitis C virus in selected groups of a Canadian urban population.

Authors:  C M Anand; K Fonseca; R P Walle; S Powell; M Williams
Journal:  Int J Epidemiol       Date:  1992-02       Impact factor: 7.196

10.  Spread of bloodborne viruses among Australian prison entrants.

Authors:  N Crofts; T Stewart; P Hearne; X Y Ping; A M Breshkin; S A Locarnini
Journal:  BMJ       Date:  1995-02-04
View more
  20 in total

1.  Identifying infectious diseases in prisons: surveillance, protection, and intervention.

Authors:  M C White
Journal:  West J Med       Date:  1999-03

Review 2.  Social determinants and the health of drug users: socioeconomic status, homelessness, and incarceration.

Authors:  Sandro Galea; David Vlahov
Journal:  Public Health Rep       Date:  2002       Impact factor: 2.792

3.  Estimating HCV prevalence at the state level: a call to increase and strengthen current surveillance systems.

Authors:  Rachel Hart-Malloy; Alvaro Carrascal; A Gregory Dirienzo; Colleen Flanigan; Kristi McClamroch; Lou Smith
Journal:  Am J Public Health       Date:  2013-06-13       Impact factor: 9.308

4.  Prevalence and correlates of Hepatitis C among injection drug users: The significance of duration of use, incarceration and race/ethnicity.

Authors:  William W Latimer; Sarra L Hedden; Leah Floyd; April Lawson; Alexander Melnikov; S Geoffrey Severtson; Anne-Gloria Moleko; Kristin Cole
Journal:  J Drug Issues       Date:  2009-09

5.  Toward a more accurate estimate of the prevalence of hepatitis C in the United States.

Authors:  Brian R Edlin; Benjamin J Eckhardt; Marla A Shu; Scott D Holmberg; Tracy Swan
Journal:  Hepatology       Date:  2015-08-25       Impact factor: 17.425

6.  Ongoing transmission of hepatitis B virus infection among inmates at a state correctional facility.

Authors:  Amy J Khan; Edgar P Simard; William A Bower; Heather L Wurtzel; Marina Khristova; Karla D Wagner; Kathryn E Arnold; Omana V Nainan; Madeleine LaMarre; Beth P Bell
Journal:  Am J Public Health       Date:  2005-10       Impact factor: 9.308

7.  Hepatitis C seroprevalence among prison inmates since 2001: still high but declining.

Authors:  Aiden K Varan; Daniel W Mercer; Matthew S Stein; Anne C Spaulding
Journal:  Public Health Rep       Date:  2014 Mar-Apr       Impact factor: 2.792

8.  HCV-related mortality among male prison inmates in Texas, 1994-2003.

Authors:  Amy J Harzke; Jacques G Baillargeon; Michael F Kelley; Pamela M Diamond; Karen J Goodman; David P Paar
Journal:  Ann Epidemiol       Date:  2009-05-13       Impact factor: 3.797

9.  An economic assessment of pre-vaccination screening for hepatitis A and B.

Authors:  R Jake Jacobs; Sammy Saab; Allen S Meyerhoff; Raymond S Koff
Journal:  Public Health Rep       Date:  2003 Nov-Dec       Impact factor: 2.792

10.  Prevalence of infection with hepatitis B and C viruses and co-infection with HIV in three jails: a case for viral hepatitis prevention in jails in the United States.

Authors:  Karen A Hennessey; Andrea A Kim; Vivian Griffin; Nicoline T Collins; Cindy M Weinbaum; Keith Sabin
Journal:  J Urban Health       Date:  2008-07-12       Impact factor: 3.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.